Matinas BioPharma Holdings (MTNB) Payables (2013 - 2026)
Matinas BioPharma Holdings (MTNB) posted Payables of $845,000 for Q2 2026, up 406.0% from $167,000 a year earlier and up 18.7% from the prior quarter.
Powered by 
Analysis
Matinas BioPharma Holdings (MTNB) Payables (2013 - 2026) Analysis & Trends
At the end of FY2025, Matinas BioPharma Holdings' Payables came in at $315,000, up 231.6% from FY2024.
- Annual Payables shows a five-year compound annual growth rate of -2.1% (FY2020 to FY2025).
- In prior years, Matinas BioPharma Holdings' Payables was $95,000 in FY2024 (-81.5%), $514,000 in FY2023 (-16.8%), $618,000 in FY2022 (-34.0%) and $937,000 in FY2021 (+167.8%).
- The Q2 2026 figure stands as the highest quarterly Payables since Q3 2023.
- On a year-over-year basis, Payables has increased in each of the last three quarters, with growth averaging 60.1% over the last eight quarters.
- The strongest year-over-year quarter for Payables in the past five years was Q2 2026, with growth of 406.0%; the weakest was Q2 2024, with a decline of 82.7%.
- According to Business Quant data, Payables for the three prior quarters was $712,000 (Q1 2026), $315,000 (Q4 2025) and $80,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,134.06 Bn | 1,102.65 Bn | 19.71 Bn | 6.11 Bn |
| 2 | Johnson & Johnson | 616.49 Bn | 535.01 Bn | 17.26 Bn | 20.92 Bn |
| 3 | AbbVie | 501.55 Bn | 474.66 Bn | 12.70 Bn | 33.30 Bn |
| 4 | Merck | 367.24 Bn | 321.62 Bn | 12.21 Bn | 5.96 Bn |
| 5 | Novartis Ag | 297.99 Bn | 261.98 Bn | 11.24 Bn | 4.26 Bn |
| 6 | Astrazeneca | 261.48 Bn | 235.17 Bn | 12.86 Bn | 22.89 Bn |
| 7 | Amgen | 236.17 Bn | 191.57 Bn | 7.24 Bn | 2.87 Bn |
| 8 | Gilead Sciences | 190.68 Bn | 164.87 Bn | 6.22 Bn | 674.00 Mn |
| 9 | Pfizer | 169.35 Bn | 115.99 Bn | 10.94 Bn | 7.03 Bn |
| 10 | Matinas BioPharma Holdings | 683,326.41 | -11.91 Mn | - | 845,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 845,000.00 |
| Mar 31, 2026 | 712,000.00 |
| Dec 31, 2025 | 315,000.00 |
| Sep 30, 2025 | 80,000.00 |
| Jun 30, 2025 | 167,000.00 |
| Mar 31, 2025 | 282,000.00 |
| Dec 31, 2024 | 95,000.00 |
| Sep 30, 2024 | 349,000.00 |
| Jun 30, 2024 | 238,000.00 |
| Mar 31, 2024 | 473,000.00 |
| Dec 31, 2023 | 514,000.00 |
| Sep 30, 2023 | 1.76 Mn |
| Jun 30, 2023 | 1.37 Mn |
| Mar 31, 2023 | 516,000.00 |
| Dec 31, 2022 | 618,000.00 |
| Sep 30, 2022 | 656,717.00 |
| Jun 30, 2022 | 497,151.00 |
| Mar 31, 2022 | 1.35 Mn |
| Dec 31, 2021 | 937,000.00 |
| Sep 30, 2021 | 661,998.00 |
API Access
Matinas BioPharma Holdings Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=MTNB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "MTNB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=MTNB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();